Georgia Urology

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Bladder cancer4 trials
• Prostate cancer2 trials

Phase

• Phase 32 trials
• Phase 1/21 trial

Status

• Active, not recruiting3 trials
• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• Ferring Pharmaceuticals2 trials
• PROCEPT BioRobotics2 trials
• ImmunityBio, Inc.1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Recruiting

  WATER IV PCa (AS Sub-study)

  NCT07650448· PROCEPT BioRobotics· Source

  Contact: Cyprian Adi

• Recruiting

  A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

  NCT06919965· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  WATER IV Prostate Cancer

  NCT06651632· PROCEPT BioRobotics· Source

• Recruiting

  A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

  NCT06545955· Phase 3· Ferring Pharmaceuticals· Source

  Contact: Ferring Pharmaceuticals

• Active, not recruiting

  A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

  NCT02138734· Phase 1/2· ImmunityBio, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer1 recruiting
• Prostate cancer1 recruiting

Closed trials

• Terminated

  ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

  NCT06026332· Ferring Pharmaceuticals· Source